alexa Novel flavaglines displaying improved cytotoxicity.
Oncology

Oncology

Advances in Oncology Research and Treatments

Author(s): Thuaud F, Ribeiro N, Gaiddon C, Cresteil T, Dsaubry L, Thuaud F, Ribeiro N, Gaiddon C, Cresteil T, Dsaubry L

Abstract Share this page

Abstract Novel flavagline analogues were synthesized and examined with respect to their cytotoxicity. Structural features critical to the potential of this class of anticancer natural products were unraveled. We demonstrated, in particular, that the introduction of substituants at C-2 has a deleterious effect on multidrug resistance. Replacement of the hydroxy at C-1 by an aminoformyl with the opposite configuration enhances the cytotoxicity and led to a compound that reduces tumors growth in an allograft model at nontoxic doses. This article was published in J Med Chem and referenced in Advances in Oncology Research and Treatments

Relevant Expert PPTs

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords